13-02-2020
Michael Vi / Shutterstock.com
US biotechnology company 10x Genomics has won an import ban against its rival Bio-Rad Laboratories in a long-running patent dispute.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
10x Genomics, Bio-Rad Laboratories, US International Trade Commission, ITC, microfluidics
Bio-Rad and 10X Genomics end patent fight with new licensing deal
29-07-2021
Bio-Rad asks for review of DNA patent ruling
17-06-2021
Federal Circuit upholds another ITC decision in 10X vs Bio-Rad
03-06-2021
Fed Circ. agrees Bio-Rad infringed 10x patents
04-05-2021
Fed Circuit orders new Bio-Rad trial, but upholds $24m award
04-08-2020
USITC to review long-running Zimmer/Heraeus trade secrets dispute
14-07-2020
Munich court rules for Bio-Rad in 10x Genomics dispute
03-12-2019
